Copper supplementation in cancer cells enhanced PD-L1 expression, driving cancer immune evasion, while copper chelation promoted ubiquitin-mediated degradation of PD-L1 and increased the number of tumor-infiltrating CD8+T and natural-killer cells (Voli et al., 2020). The gene discussed is CD274; the disease is neoplasm.